James Paul Lang

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
9 years
Director since
2023

9 years of board service in total across 3 boards, counting each seat separately. Longest: OptimizeRx Corporation, 3 years.

3 years · Since 2023
BioVie Inc. Director
3 years · Since 2023
11 months · Since 2025

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 9, 2026 OptimizeRx Corporation Grant or award +34,517 — —
May 5, 2026 Halozyme Therapeutics Inc. Grant or award +3,796 — —
Jan 2, 2026 Halozyme Therapeutics Inc. Grant or award +889 — —
Jun 11, 2025 OptimizeRx Corporation Grant or award +9,868 — —
Mar 14, 2025 OptimizeRx Corporation Open-market purchase +321,408 $7.60 $2,442,701
Jun 7, 2024 OptimizeRx Corporation Grant or award +13,286 — —
Jun 5, 2024 OptimizeRx Corporation Option exercise +10,061 — —
Jun 7, 2023 OptimizeRx Corporation Option exercise +4,637 — —
Mar 30, 2023 OptimizeRx Corporation Option exercise +657 — —
Dec 30, 2022 OptimizeRx Corporation Option exercise +409 — —
Nov 23, 2022 BioVie Inc. Grant or award +43,578 — —

Questions about James Paul Lang

What boards is James Paul Lang on?

James Paul Lang sits on the boards of BioVie Inc., Halozyme Therapeutics Inc. and OptimizeRx Corporation.

How long has James Paul Lang served on boards?

Our records show at least 9 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.